Spotlight on Impactful Research: Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study
Jasleen Singh, Eric R. Kallwitz – 30 June 2020
Spotlight on Impactful Research: Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study
Jasleen Singh, Eric R. Kallwitz – 30 June 2020
Highlights From the AASLD/EASL ALD Endpoints Conference 2019
Madeline Bertha, Haripriya Maddur – 30 June 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine
George V. Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, W. Ray Kim – 30 June 2020
Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis
Sang Bong Ahn, Elizabeth E. Powell, Anthony Russell, Gunter Hartel, Katharine M. Irvine, Chris Moser, Patricia C. Valery – 30 June 2020 – Although there is evidence that type 2 diabetes mellitus (T2D) impacts adversely on liver‐related mortality, its influence on hospital readmissions and development of complications in patients with cirrhosis, particularly in alcohol‐related cirrhosis (the most common etiological factor among Australian hospital admissions for cirrhosis) has not been well studied.
Cholangitis Lenta: What Hepatologists Need to Know
Adam L. Booth, Shehzad N. Merwat, Sheharyar K. Merwat, Heather L. Stevenson – 30 June 2020
Cause for Confusion: Noncirrhotic Hyperammonemic Encephalopathy
Avash Kalra, J. P. Norvell – 30 June 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine
George V. Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, W. Ray Kim – 30 June 2020
Fatal COVID‐19 in a Patient with End‐Stage Liver Disease Wait‐Listed for Liver Transplantation: An Evidence‐Based Review of COVID‐19 Screening Modalities Prior to Transplant
Yoona Rhee, Edie L. Chan, Sheila L. Eswaran, Costica Aloman, Martin Hertl, Carlos A.Q. Santos – 30 June 2020